摘要
经过近70年的艰苦努力,我国寄生虫病防治工作取得了举世瞩目的成就,一些重要寄生虫病已经达到或正在迈向消除。随着社会和经济的发展、"一带一路"倡议的逐步实施和推进、国内外交流和对外投资的增加,我国外出务工、经商、留学、旅游、探亲以及参与国内外交流活动的人员日益增多,导致国内从流行区到非流行区、全球从国外到国内的输入性寄生虫病病例逐渐增多。输入性病例增多给我国寄生虫病消除工作带来了新的挑战。本文分析了我国疟疾、血吸虫病和利什曼病这3种重要输入性寄生虫病的流行现状及当前防控工作面临的新挑战,并提出了相关应对策略和措施。
Following the concerted efforts for nearly 70 years, great achievements have been obtained in parasitic diseases control in China, and some important parasitic diseases have been eliminated or moving towards elimination in the country. With the socioeconomic development, the implementation of the"Road and Belt Initiative"and the increase in the international communication and overseas investment, there is a rise in the number of overseas labors, businessmen, students, travelers, visitors and participants in national and international communication activities, resulting in a gradual increase in the number of cases with parasitic diseases imported from endemic to non-endemic areas of China and from foreign countries to China. The increase in the number of imported cases causes new challenges for the elimination of parasitic diseases in China. The paper describes the current status of malaria, schistosomiasis and leishmaniasis, analyzes the challenges for the current control activities, and proposes the control strategies and interventions.
作者
杜海娟
闻礼永
周晓农
DU Hai-Juan;WEN Li-Yong;ZHOU Xiao-Nong(Institute of Parasitic Diseases,Zhejiang Academy of Medical Sciences,Hangzhou 310013,China;National Institute of Parasitic Diseases,Chinese Center for Disease Control and Prevention,WHO Collaborating Center for Tropical Diseases,Chinese Center for Tropical Diseases Research,National Center for International Research on Tropical Diseases,Ministry of Science and Technology,Key Laboratory of Parasite and Vector Biology,National Health Commission,China)
出处
《中国血吸虫病防治杂志》
CAS
CSCD
北大核心
2019年第4期353-355,367,共4页
Chinese Journal of Schistosomiasis Control
基金
国家科技重大专项（2018ZX10101002-002）
国家社会科学基金重大项目（16ZDA237）
上海市公共卫生三年行动计划（GWIV-29）
关键词
疟疾
血吸虫病
利什曼病
输入性病例
挑战
对策
Malaria
Schistosomiasis
Leishmaniasis
Imported case
Challenge
Countermeasure
